{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:48:21Z","timestamp":1790153301686,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ymgme.2010.06.003","type":"journal-article","created":{"date-parts":[[2010,6,23]],"date-time":"2010-06-23T08:31:15Z","timestamp":1277281875000},"page":"130-133","source":"Crossref","is-referenced-by-count":49,"title":["Pompe disease: Dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three later-onset patients"],"prefix":"10.1016","volume":"101","author":[{"given":"Donna L.","family":"Bernstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lakshmi","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Desnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2010.06.003_bb0005","first-page":"304","article-title":"Over idiopathische hypertrophie van het hart","volume":"76","author":"Pompe","year":"1932","journal-title":"Ned. Tijdschr. Geneeskd"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1542\/peds.112.2.332","article-title":"The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature","volume":"112","author":"van den Hout","year":"2003","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ymgme.2010.06.003_bb0015","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jpeds.2005.11.033","article-title":"Infantile-Onset Pompe Disease Natural History Study Group, A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease","volume":"148","author":"Kishnani","year":"2006","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ymgme.2010.06.003_bb0020","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198204153061515","article-title":"Cardiac arrhythmias and the adult form of type II glycogenosis, (Letter)","volume":"306","author":"Francesconi","year":"1982","journal-title":"New Eng. J. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2010.06.003_bb0025","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2796.2008.01966.x","article-title":"Cardiac involvement in adults with Pompe disease","volume":"264","author":"Soliman","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ymgme.2010.06.003_bb0030","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/(SICI)1096-8628(19980827)79:1<69::AID-AJMG16>3.0.CO;2-K","article-title":"Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease","volume":"79","author":"Martiniuk","year":"1998","journal-title":"Am. J. Med. Genet."},{"issue":"6","key":"10.1016\/j.ymgme.2010.06.003_bb0035","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/sj.ejhg.5200367","article-title":"Frequency of glycogen storage disease type II in The Netherlands: implications for diagnosis and genetic counselling","volume":"7","author":"Ausems","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"issue":"4","key":"10.1016\/j.ymgme.2010.06.003_bb0040","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1086\/301788","article-title":"The African origin of the common mutation in African American patients with glycogen-storage disease type II","volume":"62","author":"Becker","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2010.06.003_bb0045","first-page":"3389","article-title":"Glycogen Storage Disease Type II; Acid-glucosidase (Acid Maltase) Deficiency","volume":"Vol. III","author":"Hirschhorn","year":"2001"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0050","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cccn.2004.04.009","article-title":"Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper","volume":"347","author":"Chamoles","year":"2004","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0055","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/01.gim.0000217781.66786.9b","article-title":"Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease","volume":"8","author":"Zhang","year":"2006","journal-title":"Genet. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2010.06.003_bb0060","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ymgme.2006.12.006","article-title":"Rapid diagnosis of late-onset Pompe disease by fluorometric assay of alpha-glucosidase activities in dried blood spots","volume":"90","author":"Kallwass","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2010.06.003_bb0065","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.gim.0000218152.87434.f3","article-title":"Pompe disease diagnosis and management guideline","volume":"8","author":"Kishnani","year":"2006","journal-title":"Genet. Med."},{"issue":"1","key":"10.1016\/j.ymgme.2010.06.003_bb0070","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1055\/s-0029-1231066","article-title":"Treatment of gastroesophageal reflux with nissen fundoplication and gastrostomy tube insertion in infantile pompe's disease","volume":"40","author":"Hirschburger","year":"2009","journal-title":"Neuropediatrics"},{"issue":"7","key":"10.1016\/j.ymgme.2010.06.003_bb0075","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.1111\/j.1468-1331.2009.02667.x","article-title":"Enzyme replacement therapy in late-onset type II glycogenosis","volume":"16","author":"Ravaglia","year":"2009","journal-title":"Eur. J. Neurol."},{"issue":"8","key":"10.1016\/j.ymgme.2010.06.003_bb0080","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00415-005-0922-9","article-title":"The natural course of non-classic Pompe's disease; a review of 225 published cases","volume":"252","author":"Winkel","year":"2005","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2010.06.003_bb0085","article-title":"Oropharyngeal dysphagia in infants and children with infantile Pompe disease","author":"Jones","year":"2009","journal-title":"Dysphagia"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0090","series-title":"PolyPhen: prediction of functional effect of human nsSNPs","year":"2010"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0095","series-title":"Pompe mutation database","year":"2010"},{"issue":"3","key":"10.1016\/j.ymgme.2010.06.003_bb0100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1203\/PDR.0b013e3181b24e94","article-title":"Early treatment with alglucosidase alpha prolongs long-term survival of infants with Pompe disease","volume":"66","author":"Kishnani","year":"2009","journal-title":"Pediatr. Res."},{"issue":"11","key":"10.1016\/j.ymgme.2010.06.003_bb0105","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1007\/s00415-009-5219-y","article-title":"Pompe disease in a Brazilian series: clinical and molecular analyses with identification of nine new mutations","volume":"256","author":"Oba-Shinjo","year":"2009","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2010.06.003_bb0110","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0887-8994(02)00413-7","article-title":"L-alanine supplementation in late infantile glycogen storage disease type II","volume":"27","author":"Bodamer","year":"2002","journal-title":"Pediatr. Neurol."},{"issue":"2","key":"10.1016\/j.ymgme.2010.06.003_bb0115","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/(SICI)1098-1004(1997)10:2<128::AID-HUMU5>3.0.CO;2-G","article-title":"Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans","volume":"10","author":"Adams","year":"1997","journal-title":"Hum. Mutat."},{"issue":"4","key":"10.1016\/j.ymgme.2010.06.003_bb0120","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0887-8994(03)00267-4","article-title":"New GAA mutations in Japanese patients with GSDII (Pompe disease)","volume":"29","author":"Pipo","year":"2003","journal-title":"Pediatr. Neurol."},{"issue":"85","key":"10.1016\/j.ymgme.2010.06.003_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ymgme.2005.04.009","article-title":"Gastrointestinal manifestations of Fabry disease: clinical response to enzyme replacement therapy","author":"Banikazemi","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.ymgme.2010.06.003_bb0130","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease, clinical, laboratory, radiologic and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.ymgme.2010.06.003_bb0135","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/01376517-199310000-00005","article-title":"Gaucher's disease: a pilot study of the symptomatic responses to enzyme replacement therapy","volume":"25","author":"Verderese","year":"1993","journal-title":"J. Neurosci. Nurs."},{"issue":"2","key":"10.1016\/j.ymgme.2010.06.003_bb0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/mus.20896","article-title":"Both type 1 and type 2a muscle fibers can respond to enzyme therapy in Pompe disease","volume":"37","author":"Drost","year":"2008","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2010.06.003_bb0145","first-page":"424","article-title":"Expression of the insulin-like growth factor-II\/mannose-6-phosphate receptor in multiple human tissues during fetal life and early infancy","volume":"75","author":"Funk","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ymgme.2010.06.003_bb0150","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ana.20807","article-title":"Dysfunction of endocytic and autophagic pathways in a lysosomal storage disease","volume":"59","author":"Fukuda","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.ymgme.2010.06.003_bb0155","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ymthe.2006.08.009","article-title":"Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease","volume":"14","author":"Fukuda","year":"2006","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.ymgme.2010.06.003_bb0160","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ymgme.2007.04.018","article-title":"Differential muscular glycogen clearance after enzyme replacement therapy in a mouse model of Pompe disease","volume":"91","author":"Hawes","year":"2007","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.ymgme.2010.06.003_bb0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/labinvest.3700484","article-title":"Characterization of pre- and post-treatment pathology after enzyme replacement therapy for Pompe disease","volume":"86","author":"Thurberg","year":"2006","journal-title":"Lab. Invest."},{"issue":"23","key":"10.1016\/j.ymgme.2010.06.003_bb0170","doi-asserted-by":"crossref","first-page":"9419","DOI":"10.1073\/pnas.0902534106","article-title":"Neural deficits contribute to respiratory insufficiency in Pompe disease","volume":"106","author":"DeRuisseau","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719210002234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T06:50:41Z","timestamp":1544424641000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719210002234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":34,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1096719210002234"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2010.06.003","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}